Businessweek

Bayer%20HealthCare%2C%20LLC%20signed%20a%20merger%20agreement%20to%20acquire%20Conceptus%2C%20Inc.%20%28NasdaqGS%3ACPTS%29%20from%20a%20group%20of%20investors%20for%20%241.1%20billion%20on%20April%2028%2C%202013.%20The%20group%20of%20investors%20include%20Camber%20Capital%20Management%20LLC%2C%20VantagePoint%20Venture%20Partners%20IV%2C%20L.P.%2C%20a%20fund%20of%20VantagePoint%20Capital%20Partners%2C%20Federated%20Investors%2C%20Inc.%20%28NYSE%3AFII%29%27s%20funds-%20Federated%20Insurance%20Series%20-%20Federated%20Kaufmann%20Fund%20II%2C%20Federated%20Equity%20Funds%20-%20Federated%20Kaufmann%20Small%20Cap%20Fund%20%28MutualFund%3AFKCS.X%29%20and%20Federated%20Global%20Investment%20Management%20Corp.%2C%20Fidelity%20Management%20%26%20Research%20Company%2C%20William%20Blair%20%26%20Company%2C%20L.L.C.%2C%20Asset%20Management%20Arm%2C%20T.%20Rowe%20Price%20Associates%2C%20Inc.%20and%20others.%20Bayer%20will%20pay%20%2431%20for%20each%20share%20of%20Conceptus.%20Each%20outstanding%20option%20and%20stock%20appreciation%20right%20of%20Conceptus%20will%20be%20cancelled%20and%20each%20former%20holder%20will%20receive%20a%20cash%20amount%20equal%20price%20in%20excess%20of%20exercise%20price%20per%20option.%20In%20addition%2C%20each%20outstanding%20Conceptus%u2019s%20restricted%20stock%20unit%20will%20be%20cancelled%20and%20each%20former%20holder%20will%20receive%20a%20cash%20amount%20equal%20offer%20price.%0D%0A%0D%0AThe%20tender%20offer%20will%20commence%20on%20or%20before%20May%2010%2C%202013.%20The%20tender%20offer%20will%20last%2020%20days%20from%20the%20date%20of%20start%20of%20the%20offer.%20Bayer%20HealthCare%20will%20exercise%20the%20top%20up%20option%20to%20acquire%20remaining%20stake%20if%20it%20acquires%20at%20least%2090%25%20of%20Conceptus%20shares%20through%20tender%20offer.%20Conceptus%20may%20be%20required%20to%20pay%20Bayer%20HealthCare%20a%20termination%20fee%20of%20%2437.3%20million.%0D%0A%0D%0AThe%20transaction%20is%20subject%20to%20customary%20closing%20conditions%2C%20including%20Conceptus%20shareholders%2C%20US%20anti-trust%20approval%20and%20is%20expected%20to%20complete%20by%20mid%202013.%20The%20Board%20of%20Directors%20of%20Conceptus%20and%20Bayer%20HealthCare%20have%20unanimously%20approved%20the%20transaction%20and%20recommended%20the%20shareholders%20to%20accept%20the%20same.%20As%20of%20May%207%2C%202013%2C%20Bayer%20commenced%20a%20cash%20tender%20offer%20for%20all%20the%20shares%20of%20Conceptus%2C%20Inc.%0D%0A%0D%0AGoldman%2C%20Sachs%20%26%20Co.%20acted%20as%20financial%20advisor%20for%20Conceptus.%20Michael%20W.%20Hall%2C%20Josh%20Dubofsky%2C%20Robert%2C%20Kirt%20Switzer%2C%20Grace%20Chen%2C%20James%20Metz%2C%20Karen%20Silverman%2C%20Joshua%20Holian%2C%20J.D.%20Marple%2C%20John%20Manthei%2C%20Gregory%20Rodgers%20and%20Peter%20F.%20Kerman%20of%20Latham%20%26%20Watkins%20LLP%20acted%20as%20legal%20advisors%20for%20Conceptus.%20Matthew%20G.%20Hurd%2C%20Nader%20A.%20Mousavi%20and%20Ronald%20E.%20Creamer%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisors%20for%20Bayer%20AG.%20Bank%20of%20America%20Merrill%20Lynch%20acted%20as%20financial%20advisor%20and%20Jones%20Day%20acted%20as%20legal%20advisor%20for%20Bayer.%20Damien%20R.%20Zoubek.%20of%20Cravath%2C%20Swaine%20%26%20Moore%20LLP%20acted%20as%20legal%20advisor%20to%20Goldman%20Sachs%20in%20the%20transaction.